No difference in tolerability was found between Depakote DR and Depakote ER in elderly patients. Overnight conversion was tolerated the same as a seven day
Hair loss is possible with Depakote and Depakote ER. This side effect was common in clinical trials of Depakote DR tablets, Depakote ER tablets, and Depakote DR sprinkle capsules.
This application intends to support the conversion ofDepakote DR to Depakote ER if the Depakote ER doses are 8-20% higher than that of Depakote DR tablets. A dose conversion table is provided in the label for conversion from Depakote DR to Depakote ER tablets based on the results from the two studies submitted in this application. RECOMMENDATION
Depakote ER or Depakote DR for acute mania or mixed mania Subjects who have failed previous trials with Depakote DR or Depakote ER.
Depakote ER and Depakote DR. NCT . 2024
This application intends to support the conversion ofDepakote DR to Depakote ER if the. Depakote ER doses are 8-20% higher than that of.
Divalproex DR vs. Divalproex ER Divalproex DR (delayed-release) is the equivalent of Depakote. In this case delayed-release simply means
Conclusions: No difference in tolerability was found between Depakote DR and Depakote ER in elderly patients. Overnight conversion was tolerated
TABLE OF CONTENTS. EXECUTIVE SUMMARY conversion table is provided in the label for conversion from Depakote DR to Depakote.
Comments